Previous Page  186 / 327 Next Page
Information
Show Menu
Previous Page 186 / 327 Next Page
Page Background

186

• Annual Report 2018-19

Shaping the future of software driven business

Other Current assets (other than financial assets)

Other Current assets other than financial assets include following:

(In

`

Million)

Particulars

As at March 31, 2019 As at March 31, 2018

Current tax assets (net)

110.26

113.99

Other current assets

1,387.79

1,563.41

Total

1,498.05

1,677.40

Other current assets include advances recoverable in cash or kind within period of twelve months from the Balance Sheet date

and VAT receivable, Service Tax and GST receivable.

Current ratio was 3.90 as at March 31, 2019 as against 3.56 as at March 31, 2018.

Non-current liabilities:

(In

`

Million)

Particulars

As at March 31, 2019 As at March 31, 2018

Financial liabilities

- Borrowings (non-current portion)

11.97

16.55

Provisions

252.80

159.75

Total

264.77

176.30

Non-current financial liabilities - Borrowings

Under the scheme of Biotechnology Industry Partnership Program of Department of Biotechnology (DBT), Ministry of Science

and Technology, Government of India, financial aid is given to all the partners involved in the research project undertaken by

the Ministry of Science and Technology in the field of biotechnology. The Company being an industrial partner, the aid is in the

form of a long-term loan at a nominal rate of interest of 2% p.a. Based on the project costs, an amount of

`

21.80 Million has

been sanctioned as a long-term loan. Loan amount outstanding under this scheme amounted to

`

5.46 Million as on March 31,

2019 as against

`

8.19 Million as on March 31, 2018. The loan amount is repayable in ten equal semiannual installments over a

period of five years starting from March 2016.

Under the scheme of NMITLI (New Millennium India Technology Leadership Initiative), the Company has undertaken a project

on the ‘System based Computational Model of Skin’. As a part of this scheme, Council for Scientific and Industrial Research

(CSIR) has granted a financial help in the form of a loan at a nominal rate of interest of 3% p.a. Based on the project costs,

an amount of

`

40.71 Million has been sanctioned as a long-term loan. The loan is repayable in ten equal annual installments

commencing from September 2015. Loan amount outstanding under this scheme amounted to

`

11.09 Million as on March 31,

2019 as against

`

12.94 Million as on March 31, 2018. Please refer Note 19 of the consolidated financials for details.

The interest of

`

0.17 Million (previous year

`

0.78 Million) is accrued but not due on these loans. Out of the total outstanding

balance of

`

16.72 Million, the balance of

`

4.75 Million is repayable within twelve months from the Balance Sheet date and hence,

reclassified to Other Current Financial Liabilities. The reduction in overall balance of borrowings represents the repayment of

borrowings as per the repayment schedule in the agreements.

Debt-equity ratio as at March 31, 2019 was 0.0007 as against 0.001 as at March 31, 2018.

Non-current liabilities - Provisions

The long-term provisions are those provisions which are not expected to be settled within twelve months from the date of the

Balance Sheet. Long term provisions include the liability towards long service award and gratuity payable to the employees. The

total long-term provisions have increased to

`

252.80 Million as at March 31, 2019 as compared to

`

159.75 Million as at March

31, 2018 mainly due to increase in provision for gratuity. The Company provides for gratuity on the basis of actuarial valuation

basis using the projected unit credit method at the reporting date. This provision stood at

`

94.34 Million as at March 31, 2019 as

against

`

16.38 Million as at March 31, 2018. Increase in gratuity is due to deficit in funding of plan asset. The Company expects

to contribute the entire deficit to gratuity fund in financial year 2019-20.

The provision for long service awards has increased from

`

143.37 Million as at March 31, 2018 to

`

158.46 Million as at March

31, 2019. Please refer Note 20 of the consolidated financials for details.